- The European Medicines Agency (EMA) expects to decide on the authorization for Pfizer Inc (NYSE:PFE) / BioNTech SE (NASDAQ:BNTX) COVID-19 booster shot at the beginning of October, Reuters reported citing a source directly familiar with the matter.
- The European decision will follow the FDA authorization granted for the additional dose of the vaccine for certain populations.
- Related Content: Pfizer COVID-19 Vaccine Booster Shot Approved By FDA For High-Risk Individuals, People 65 And Up.
- “EMA’s decision on the third dose of Pfizer is expected for the beginning of October,” Reuters reported quoting the source who stayed anonymous because of the sensitivity of the matter.
- Many EU nations have already decided to administer booster COVID-19 shots despite facing higher legal risks without a formal decision by the EMA.
- Related Content: EU Says Without EMA Approval COVID-19 Boosters May Face Higher Legal Risks: Reuters.
- Pfizer and BioNTech have signed three deals to deliver 2.4 billion vaccine doses to the EU.
- The latest deal covers 900 million doses, with a significant portion likely necessary if booster shots are needed.
- Moderna Inc (NASDAQ:MRNA) made regulatory submissions to the EMA seeking conditional marketing approval for its COVID-19 booster shot early this month.
- Related Content: After Pfizer, Now Moderna Touts Data Supporting COVID-19 Booster Dose.
- Price Action: PFE stock is up 1.18% at $44.47, while BNTX stock is up 3.66% at $351.84 during the market session on the last check Thursday.
- Photo by Johaehn from Pixabay
Deutsche Bank Maintains Hold on Ford Motor, Lowers Price Target to $12
Deutsche Bank analyst Emmanuel Rosner maintains Ford Motor (NYSE:F) with a Hold and lowers the price target from $17 to $12.
